Show simple item record

dc.contributor.authorFish, Rebecca
dc.contributor.authorSanders, C
dc.contributor.authorRyan, N
dc.contributor.authorder Veer, S
dc.contributor.authorRenehan, Andrew G
dc.contributor.authorWilliamson, P
dc.date.accessioned2018-05-05T19:12:45Z
dc.date.available2018-05-05T19:12:45Z
dc.date.issued2018-05
dc.identifier.citationSystematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC). 2018, 20(5): 371-382 Colorectal Disen
dc.identifier.issn1463-1318
dc.identifier.pmid29566456
dc.identifier.doi10.1111/codi.14103
dc.identifier.urihttp://hdl.handle.net/10541/620983
dc.description.abstractSix Phase III randomized trials have determined the effectiveness of chemoradiotherapy as primary treatment for anal squamous cell carcinoma (ASCC), but outcomes reported in these trials varied widely, hindering evidence synthesis. To improve reporting in all future trials, we aim to develop a core outcomes set (COS). As the first stage of COS development, we undertook a systematic review to summarize the outcomes reported in studies evaluating chemoradiotherapy for ASCC.
dc.language.isoenen
dc.rightsArchived with thanks to Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Irelanden
dc.titleSystematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC).en
dc.typeArticleen
dc.contributor.departmentDivision of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Vaughan House, Portsmouth Street, Manchester, M13 9GBen
dc.identifier.journalColorectal Diseaseen
refterms.dateFOA2018-12-17T15:21:23Z
html.description.abstractSix Phase III randomized trials have determined the effectiveness of chemoradiotherapy as primary treatment for anal squamous cell carcinoma (ASCC), but outcomes reported in these trials varied widely, hindering evidence synthesis. To improve reporting in all future trials, we aim to develop a core outcomes set (COS). As the first stage of COS development, we undertook a systematic review to summarize the outcomes reported in studies evaluating chemoradiotherapy for ASCC.


Files in this item

Thumbnail
Name:
Fish_et_al-2018-Colorectal_Dis ...
Size:
343.3Kb
Format:
PDF
Description:
Open access full text article

This item appears in the following Collection(s)

Show simple item record